Dr. Thomas Nevill founded the Bone Marrow Transplant Program of Atlantic Canada in 1991 and acted as its Director for five years. He joined the Leukemia/Bone Marrow Transplant Program of BC in 1996.
His research interests include prognostic factors and new therapies in myelodysplastic syndrome (MDS), prevention and treatment of graft-versus-host disease (GVHD), and attempting to reduce the psychological impact of bone marrow transplant on patients and families.
Dr. Thomas Nevill founded the Bone Marrow Transplant Program of Atlantic Canada in 1991 and acted as its Director for five years. He joined the Leukemia/Bone Marrow Transplant Program of BC in 1996.
